Insulin secretion
Showing 26 - 50 of 9,960
Type 2 Diabetes, Morbid Obesity Trial in Tønsberg (Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy,
Active, not recruiting
- Type 2 Diabetes
- Morbid Obesity
- Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy
- +2 more
-
Tønsberg, Vestfold, NorwayThe Morbid Obesity Center, Vestfold Hospital Trust
Jun 1, 2022
Metabolic Syndrome X Trial in Guadalajara (Banaba, )
Completed
- Metabolic Syndrome X
- Banaba
- placebo
-
Guadalajara, Jalisco, MexicoIntstituto de Terapeútica Experimental y Clínica. Centro Univers
Dec 25, 2020
Obesity Trial in Guadalajara (Tadalafil, Placebo)
Completed
- Obesity
- Tadalafil
- Placebo
-
Guadalajara, Jalisco, MexicoInstituto de Terapéutica Experimental y Clínica
Sep 16, 2020
Glucose Intolerance Trial in Guadalajara (Artemisia dracunculus, Placebo)
Completed
- Glucose Intolerance
- Artemisia dracunculus
- Placebo
-
Guadalajara, Jalisco, MexicoManuel González Ortiz
Sep 11, 2020
Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance Trial in Guadalajara (Dapagliflozin, Placebo)
Completed
- Prediabetes
- +2 more
- Dapagliflozin
- Placebo
-
Guadalajara, Jalisco, MexicoIntstituto de Terapeútica Experimental y Clínica. Centro Univers
Oct 6, 2020
Metabolic Syndrome X Trial in Guadalajara (Dapagliflozin, Placebo)
Completed
- Metabolic Syndrome X
- Dapagliflozin
- Placebo
-
Guadalajara, Jalisco, MexicoInstituto de Terapeútica Experimental y Clínica. Centro Universi
Oct 6, 2020
Diabetes Type 2 Trial in Guadalajara (Momordica charantia, Placebo)
Completed
- Diabetes Mellitus Type 2
- Momordica charantia
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics (INTEC), CUC
Sep 29, 2020
Metabolic Syndrome X Trial in Guadalajara (Irvingia gabonensis, Placebo)
Completed
- Metabolic Syndrome X
- Irvingia gabonensis
- Placebo
-
Guadalajara, Jalisco, MexicoInstituto de Terapéutica Experimental y Clínica
Sep 11, 2020
Type 2 Diabetes Trial in Copenhagen (Endurance exercise training, Semaglutide)
Recruiting
- Type 2 Diabetes
- Endurance exercise training
- Semaglutide
-
Copenhagen, DenmarkXlab, Center for Healthy Aging, Department of Biomedical Science
Feb 8, 2021
Impaired Glucose Tolerance Trial in Guadalajara (Gymnema Sylvestre, Placebo)
Completed
- Impaired Glucose Tolerance
- Gymnema Sylvestre
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics (INTEC), CUC
Jan 14, 2021
Metabolic Syndrome X Trial in Guadalajara (Resveratrol, Placebo)
Completed
- Metabolic Syndrome X
- Resveratrol
- Placebo
-
Guadalajara, Jalisco, MexicoIntstituto de Terapeútica Experimental y Clínica. Centro Univers
Aug 28, 2020
Metabolic Syndrome Trial in Quebec (Monounsaturated fatty acids diet, Saturated fatty acids diet)
Recruiting
- Metabolic Syndrome
- Monounsaturated fatty acids diet
- Saturated fatty acids diet
-
Quebec, CanadaInstitute of Nutrition and Functional Foods (INAF)
Aug 31, 2021
Diabetes, Type 2 Trial in Kuwait (GLP-1 receptor agonist)
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Kuwait, KuwaitDasman Diabetes Institute
Jul 19, 2020
Bariatric Surgery Candidate, Glucose Intolerance, Insulin Resistance Trial (Dexmedetomidine, 0.9% Sodium-chloride, Fentanyl)
Completed
- Bariatric Surgery Candidate
- +2 more
- Dexmedetomidine
- +3 more
- (no location specified)
Sep 9, 2020
Neonatal Diabetes Trial in Exeter (High protein meal, High carbohydrate meal, Paracetamol)
Unknown status
- Neonatal Diabetes
- High protein meal
- +3 more
-
Exeter, Devon, United KingdomExeter Clinical Research Facility
Mar 9, 2020
Type II Diabetes Trial in San Antonio (Dapagliflozin, Placebo)
Completed
- Type II Diabetes Mellitus
- Dapagliflozin
- Placebo
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Sep 15, 2020
Obesity, Insulin Resistance Trial in Stanford (Low-Carbohydrate Diet, Low-Fat Diet, Mobile App)
Completed
- Obesity
- Insulin Resistance
- Low-Carbohydrate Diet
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Aug 6, 2020
Insulin Resistance, Endothelial Dysfunction Trial (GHRP-3 low dose, GHRP-3 high dose, Saline)
Withdrawn
- Insulin Resistance
- Endothelial Dysfunction
- GHRP-3 low dose
- +2 more
- (no location specified)
Jan 6, 2021
Towards Precision Medicine for Diabetes in Pregnancy
Recruiting
- Gestational Diabetes
- Gestational Diabetes Mellitus
-
Heerlen, NetherlandsZuyderland Medisch Centrum
Jul 10, 2023
OGTT in Post-pancreatitis Diabetes Mellitus for Diagnosis and
Recruiting
- Chronic Pancreatitis
- +3 more
- blood test
- Continuous Glucose Monitor
-
Shanghai, Shanghai, ChinaDepartment of Gastroenterology, Changhai Hospital
Aug 11, 2023
Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Phenofibrate
- Placebo
-
Warsaw, Mazowieckie, Poland
- +1 more
Jun 8, 2023
Effects of Bariatric Surgery on Insulin
Completed
- Obesity
- +4 more
-
Phoenix, ArizonaNIDDK, Phoenix
Dec 14, 2019
Diabetes Trial in Trondheim (metformin+ NPH insulin, metformin + sitagliptin +/- repaglinide)
Completed
- Diabetes
- metformin+ NPH insulin
- metformin + sitagliptin +/- repaglinide
-
Trondheim, NorwayValdemar Grill
Jan 8, 2020